We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Two months into the new federal fiscal year, generic approvals are faring considerably better compared to the same year-ago time frame, according to the FDA’s Generic Drug Program database. Read More
The UK’s Medicines and Healthcare products Regulatory Agency has given its blessing to AstraZeneca's Tagrisso as part of the Early Access to Medicines Scheme. Read More